Thomas Gad, See remarks at Y-mAbs Therapeutics, Inc. (YMAB), sold 64,000 shares at $17.58 ($1.1M) on 2021-12-07, disclosed to the SEC on 2021-12-08.
Open-market sale of $1.1M YMAB by See remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.48 | 40,000 | $659K | 61.2% |
| 2 | $16.50 | 4,000 | $66K | 6.1% |
| 3 | $17.58 | 10,000 | $176K | 16.3% |
| 4 | $17.58 | 10,000 | $176K | 16.3% |
| Total | $16.82 avg | 64,000 | $1.1M | 100% |
| Filing → |
| YMAB | SELL | 2024-06-11 | $841K | — | Filing → |
| YMAB | SELL | 2024-05-23 | $396K | — | Filing → |
| YMAB | SELL | 2024-03-07 | $128K | — | Filing → |